AI
Aibotics Inc.
AIBT · OTC
$0.00 -15.38% (-$0.00)
1M +175.00%
Market Cap $484.7K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0011
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AIBT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 314.37%
Asset turnover 0.00x
ROA 380.88%
Debt
93 /100
Low Current ratio 1.67x
Int. coverage 21.55x
Debt/Equity N/A
Stability
20 /100
Unstable Beta 1.29x
Profitable years 0
EPS volatility 88.59%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AIBT
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Benjamin Kaplan
Employees
1
Headquarters
Miami